AzTrials
AzTrials

StrokeFES-UE-EXNCT07484854

FES-Assisted Upper Extremity Ergometer Training in Subacute Stroke

A study testing Upper Extremity Ergometer Training and FES-Assisted Upper Extremity Ergometer Training in people with Stroke, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Stroke is a leading cause of long-term disability and often results in impaired upper extremity function and reduced aerobic capacity. Improving both cardiovascular and function is an important goal in stroke rehabilitation. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Stroke
What is being tested?
Upper Extremity Ergometer Training and FES-Assisted Upper Extremity Ergometer Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteTurkey (Türkiye)
Study dates
9 Dec 2024to 26 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 85 years
  • Diagnosis of subacute stroke (≤6 months after stroke onset)
  • Ischemic or hemorrhagic stroke confirmed by imaging
  • Unilateral hemiplegia affecting the upper extremity
  • Brunnstrom upper extremity motor recovery stage between 1 and 5
  • Modified Ashworth Scale score <3 in the affected upper extremity
Show all 9Show fewer
  • Ability to follow simple verbal commands and cooperate with assessments
  • Medically stable and able to participate in an exercise-based rehabilitation program
  • Voluntary agreement to participate in the study and provision of written informed consent

Who cannot join

  • Severe cognitive impairment or communication disorder preventing cooperation
  • Severe cardiopulmonary disease or other medical conditions contraindicating exercise testing or training
  • Uncontrolled hypertension or cardiac arrhythmia
  • Severe musculoskeletal disorders of the upper extremity limiting participation in ergometer training
  • Presence of implanted electronic devices (e.g., pacemaker) contraindicating functional electrical stimulation
  • History of epilepsy or uncontrolled seizures
  • Severe spasticity (Modified Ashworth Scale ≥3)
  • Participation in another interventional study during the study period

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara Bilkent City Hospital

    Ankara, Çankaya, 06800

    Banu E Savtok Güler, 905543691220, banuecesavtok@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Functional Electrical Stimulation-Assisted Upper Extremity Ergometer Training on Aerobic Capacity and Upper Extremity Function in Patients With Subacute Stroke

Stroke is a leading cause of long-term disability and often results in impaired upper extremity function and reduced aerobic capacity. Improving both cardiovascular and function is an important goal in stroke rehabilitation.

This study aims to compare the effects of conventional rehabilitation combined with upper extremity ergometer training versus conventional rehabilitation combined with functional electrical stimulation (FES)-assisted upper extremity ergometer training in patients with subacute stroke.

Read more

A total of 24 patients with subacute stroke will be randomly assigned to one of two groups using the sealed envelope method. Both groups will receive conventional rehabilitation. In addition, one group will perform upper extremity ergometer training, while the other group will perform FES-assisted upper extremity ergometer training. The interventions will be applied for 30 minutes per session, for a total of 10 sessions completed over approximately four weeks.

Participants will be evaluated before and after the intervention period. Primary outcomes include aerobic capacity assessed by cardiopulmonary exercise testing and upper extremity motor function. Secondary outcomes include upper extremity strength, sensory function, functional status, and activities of daily living.

The results of this study may help determine whether adding FES-assisted upper extremity ergometer training to conventional rehabilitation provides additional benefits in improving aerobic capacity and upper extremity function in patients with subacute stroke.

Read the detailed description

Stroke frequently leads to persistent upper extremity motor impairment and reduced aerobic capacity, which negatively affect functional independence and quality of life. In the subacute phase after stroke, rehabilitation interventions that simultaneously target motor recovery and cardiovascular fitness may improve overall functional outcomes.

This study is designed as a prospective, randomized trial conducted at a single center. A total of 24 patients aged 18-85 years with subacute stroke (≤6 months after stroke onset) and unilateral hemiplegia will be included. Eligible participants must be able to follow simple commands, have a Brunnstrom upper extremity stage between 1 and 5, and have a Modified Ashworth Scale score below 3.

Participants will be allocated into two groups using the sealed envelope method. Both groups will receive conventional rehabilitation consisting of range of motion exercises, strengthening exercises, stretching, neurophysiological exercises, balance and coordination training, and functional training, applied for 45 minutes per day, five days per week, for four weeks.

In addition to conventional rehabilitation, the first group will receive upper extremity ergometer training. The second group will receive functional electrical stimulation (FES)-assisted upper extremity ergometer training. In the FES-assisted group, surface electrodes will be placed on selected upper extremity muscles according to individual needs, including wrist extensors with triceps brachii or wrist flexors with biceps brachii. Electrical stimulation will be synchronized with the ergometer cycling movement.

Upper extremity ergometer and FES-assisted ergometer training will be applied for 30 minutes per session, three days per week, for approximately four weeks, resulting in a total of 10 sessions. All interventions will be supervised by trained health care professionals.

Participants will be evaluated at baseline (before the intervention) and at the end of the 10 session intervention period. Primary outcome measures include aerobic capacity assessed by cardiopulmonary exercise testing and upper extremity motor function. Secondary outcome measures include upper extremity strength, sensory function, functional ambulation, functional independence, and activities of daily living.

The findings of this study are expected to provide evidence regarding the effectiveness of adding FES-assisted upper extremity ergometer training to conventional rehabilitation in improving aerobic capacity and upper extremity function in patients with subacute stroke.

Conditions
Stroke
Being tested
Upper Extremity Ergometer Training, FES-Assisted Upper Extremity Ergometer Training
Keywords
stroke, Functional electrical stimulation, Aerobic capacity, Stroke rehabilitation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Upper Extremity Ergometer TrainingOther

    Upper extremity ergometer training is applied for 30 minutes per session, for a total of 10 sessions over approximately four weeks, in addition to conventional rehabilitation. The training is performed using an upper extremity ergometer in a seated position under supervision.

  • FES-Assisted Upper Extremity Ergometer TrainingOther

    Functional electrical stimulation (FES)-assisted upper extremity ergometer training is applied for 30 minutes per session, for a total of 10 sessions completed over approximately four weeks, in addition to conventional rehabilitation. Surface electrical stimulation is synchronized with the ergometer movement and applied to selected upper extremity muscles according to individual needs.

Study groups in NCT07484854
Study groupRoleWhat they receive
Upper Extremity Ergometer TrainingActive comparatorParticipants receive conventional rehabilitation combined with upper extremity ergometer training.
Receives: Other: Upper Extremity Ergometer Training
FES-Assisted Upper Extremity Ergometer TrainingExperimentalParticipants receive conventional rehabilitation combined with functional electrical stimulation (FES)-assisted upper extremity ergometer training.
Receives: Other: FES-Assisted Upper Extremity Ergometer Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aerobic Capacity

    Aerobic capacity will be assessed using cardiopulmonary exercise testing by measuring peak oxygen consumption (VO2max).

    Measured: aseline and at the end of the 4 week (10 session) intervention period

  2. Upper Extremity Motor Function

    Upper extremity motor function will be evaluated using the Brunnstrom Motor Evaluation..

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

  3. Upper Extremity Motor Function

    Upper extremity motor function will be evaluated using the Fugl-Meyer Motor Assessment.

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

Secondary outcomes (4)
  1. Upper Extremity Muscle Strength

    Grip strength of the unaffected upper extremity will be measured using a hand dynamometer.

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

  2. Upper Extremity Sensory Function

    Sensory function will be assessed using the Erasmus MC Nottingham Sensory Assessment.

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

  3. Functional Independence

    Functional independence in activities of daily living will be assessed using the Modified Barthel Index.

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

  4. Health-Related Quality of Life

    Health-related quality of life will be assessed using the Nottingham Health Profile.

    Measured: Baseline and at the end of the 4 week (10 session) intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2026
  2. Study start9 Dec 2024
  3. Primary completion20 Mar 2026 (estimated)
  4. Study completion26 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are allocated into two parallel groups using the sealed envelope method and receive different upper extremity ergometer-based interventions in addition to conventional rehabilitation.
Masking
None (open label)
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07484854
Sponsor's protocol ID
TABED 1-25-876
Acronym
FES-UE-EX
Status last verified
Jan 2026
First submitted
21 Jan 2026
Last updated
20 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Upper Extremity Ergometer Training and FES-Assisted Upper Extremity Ergometer Training in people with Stroke, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aerobic Capacity (time frame: aseline and at the end of the 4 week (10 session) intervention period). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
FES-UE-EX Clinical Trial NCT07484854 | AzTrials